1,061 results on '"Belongia, Edward A"'
Search Results
2. Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017–18 through 2022–23 influenza seasons
3. Factors associated with human papillomavirus and meningococcal vaccination among adolescents living in rural and urban areas
4. Human papillomavirus vaccine beliefs and practice characteristics in rural and urban adolescent care providers
5. Lack of Evidence for Vaccine‐Associated Enhanced Disease From COVID‐19 Vaccines Among Adults in the Vaccine Safety Datalink.
6. Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022.
7. Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022.
8. Transmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020
9. Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period
10. Influenza virus shedding and symptoms: Dynamics and implications from a multi-season household transmission study
11. Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
12. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection
13. 925. Oseltamivir usage in community settings: data from a household transmission study
14. 2293. Examining social vulnerability and its effect on COVID-19 transmission in households
15. 2080. Reduced risk of SARS-CoV-2 infection among household contacts with hybrid immunity from recent COVID-19 vaccination and SARS-CoV-2 infection
16. 1789. Comparison of influenza vaccine effectiveness estimates from the US Influenza Vaccine Effectiveness Network and Electronic Health Record Source Population Data, 2021-2022
17. 400. Predictors of Post-COVID Conditions after SARS-CoV-2 Infection in Adults Enrolled in a Multistate Household Transmission Study
18. 1161. Effectiveness of the Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Infections in Outpatient Immunocompromised Adults, 2017-2018
19. 446. Post-Acute Sequelae of COVID-19 in a Rural Wisconsin Community Prospective Cohort
20. 1163. Influenza Vaccination Coverage through December among Persons Ages Six Months and Older in the Vaccine Safety Datalink, 2017-18 through 2022-23 Influenza Seasons
21. 1162. Influenza Vaccination Among Pregnant People in the Vaccine Safety Datalink, 2016-17 through 2022-23 Influenza Seasons
22. 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study
23. 1142. Impact of Informational Vaccine Notices Sent to Parents Prior to their Child’s 11th Birthday on Receipt of Adolescent Vaccines
24. 930. COVID-19 symptom and viral load rebound among individuals reporting nirmatrelvir/ritonavir use compared to propensity score matched individuals not taking COVID-19 treatment
25. Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021—June 2022
26. Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals
27. COVID-19 Booster Dose Reminder/Recall for Adolescents: Findings From a Health-Care System in Wisconsin
28. Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
29. Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness-- Wisconsin, October 2022-February 2023
30. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.
31. Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period
32. Influenza Vaccination Among Pregnant People Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic
33. Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States
34. Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons—United States, 2011–2016
35. 2015–2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States
36. Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
37. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
38. Beyond Antigenic Match : Moving Toward Greater Understanding of Influenza Vaccine Effectiveness
39. Influenza and Workplace Productivity Loss in Working Adults
40. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons
41. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013–2014 season
42. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine
43. An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children
44. Burden of medically attended influenza infection and cases averted by vaccination – United States, 2013/14 through 2015/16 influenza seasons
45. Risk of venous thromboembolism following influenza vaccination in adults aged 50 years and older in the Vaccine Safety Datalink
46. Validation of a Screening Instrument to Identify Persons for Exclusion from Smallpox Vaccination
47. Prior-Season Vaccination and Risk of Influenza During the 2014–2015 Season in the United States
48. Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015
49. Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
50. Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.